KPS develops, validates molecular diagnostic tests and provides molecular pathology services to detect predictive biomarkers in tumor samples for personalized targeted therapies
In KPS you find special know-how in molecular pathology in combination with state-of-the art R&D infrastructure and internationally trained management.
KPS is a fully independent private company, therefore intellectual property and confidentiality is most protected.
In Hungary you find EU conform regulatory environment, western-style working moral at low cost, this is why Hungary is already a preferred clinical and translational research site of international pharma companies. In addition, state and EU provided applied research grants are also available.
Gyulladásos bélbetegségek Szia,Kedvesek a metaforáid,
2010, Február 25. 23:20 Csizkat
Gyulladásos bélbetegségek Részemről eddig OK :)Nem
2010, Február 25. 14:43 chysh
Gyulladásos bélbetegségek Maga a Crohn kialakulasa
2010, Február 25. 11:53 Richard
